EUVIMEDEUVIMED entdecken
Open Access · CC BY 4.0

Silencing NRF2 enhances arsenic trioxide-induced ferroptosis in hepatocellular carcinoma cells

Mi Huang, Duanzhuo Li, Zhengzhen Xia, Shengjie Liao, Wenxia Si, Chao Yuan, Yanli Liao, Weibin Wu, Minshu Jiang, Xin Yu, Yi Quan iD

PLOS One · 2025

DOI: 10.1371/journal.pone.0322746 ↗

Kurz gefasst

Fachartikel in der Zeitschrift PLOS One, 2025. Verfasst von Mi Huang und 10 weiteren Autor:innen. Beteiligte Einrichtung: Department of Scientific Research and Experiment Center, Zhaoqing Medical College, Guangdong, People's Republic of China. Hauptthemen laut MEDLINE: Ferroptosis, Arsenic Trioxide, NF-E2-Related Factor 2, Carcinoma, Hepatocellular. Die Arbeit wurde bisher 4-mal zitiert (Crossref) und nennt 49 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: Administration of Traditional Chinese Medicine Bureau of Guangdong Province, Department of Science and Technology of Guangdong Province, Department of Education of Guangdong Province.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Objective

Hepatocellular carcinoma (HCC) is a leading cause of cancer-related deaths worldwide, with high mortality rates partially due to limited therapeutic options and drug resistance. Arsenic trioxide (ATO), a compound clinically proven for acute promyelocytic leukemia (APL), has garnered attention for its emerging efficacy in solid tumors, including HCC. However, the molecular mechanisms driving ATO’s antitumor activity in HCC remain incompletely understood. In this study, we aimed to elucidate the ferroptosis-dependent effects of ATO on HCC and and propose a potential therapeutic strategy.

Methods

The response of HCC cells to ATO was evaluated using cell viability, wound healing, colony formation, Transwell migration assays, and cell cycle analysis. ATO-induced ferroptosis was assessed by measuring lipid peroxidation (via C11-BODIPY staining), intracellular iron levels, and malondialdehyde (MDA) production. Western blotting was performed to quantify protein levels of NRF2, HO-1, SLC7A11, and GPX4; immunofluorescence staining was employed to determine NRF2 subcellular localization.

Results

ATO exhibited significant cytotoxicity and inhibited the progression of HCC cells. Treatment with ATO resulted in a notable increase in lipid ROS and MDA levels, which were subsequently reversed by the ferroptosis inhibitors Fer-1 and DFO. Mechanistically, ATO induced ferroptosis by inhibiting GPX4. Furthermore, NRF2 and its downstream targets, HO-1 and SLC7A11, were upregulated during ferroptosis. NRF2 knockdown enhanced lipid peroxidation and ATO-induced cell death.

Conclusions

ATO significantly promoted ferroptosis in HCC cells, and NRF2 knockdown enhanced the cytotoxic effects of ATO.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

FerroptosisArsenic TrioxideNF-E2-Related Factor 2Carcinoma, HepatocellularLiver NeoplasmsAntineoplastic AgentsHumansCell Line, TumorLipid PeroxidationAmino Acid Transport System y+Cell SurvivalPhospholipid Hydroperoxide Glutathione PeroxidaseGene SilencingHeme Oxygenase-1

Substanzen

Arsenic TrioxideNF-E2-Related Factor 2NFE2L2 protein, humanSLC7A11 protein, humanAmino Acid Transport System y+Antineoplastic AgentsPhospholipid Hydroperoxide Glutathione PeroxidaseHeme Oxygenase-1

Autor:innen und Institutionen

  • Department of Scientific Research and Experiment Center, Zhaoqing Medical College, Guangdong, People's Republic of China.
  • Department of Oncology, The First People's Hospital of Zhaoqing Affiliated to Zhaoqing Medical College, Guangdong, People's Republic of China.
  • The First Clinical Medical School, Guangdong Medical University, Zhanjiang, Guangdong, People's Republic of China.

ORCID-Profile: Yi Quan

Förderung

  • Administration of Traditional Chinese Medicine Bureau of Guangdong Province
  • Department of Science and Technology of Guangdong Province
  • Department of Education of Guangdong Province
  • Health Commission of Guangdong Province
  • First People's Hospital of Zhaoqing
  • Zhaoqing Medical College

Zitieren

APA

Huang, M., Li, D., Xia, Z., Liao, S., Si, W., Yuan, C., Liao, Y., Wu, W., Jiang, M., Yu, X., & Quan, Y. (2025). Silencing NRF2 enhances arsenic trioxide-induced ferroptosis in hepatocellular carcinoma cells. PLOS One. https://doi.org/10.1371/journal.pone.0322746

Vancouver

Huang M, Li D, Xia Z, Liao S, Si W, Yuan C, et al. Silencing NRF2 enhances arsenic trioxide-induced ferroptosis in hepatocellular carcinoma cells. PLOS One. 2025. doi:10.1371/journal.pone.0322746

BibTeX
@article{Huang2025,
  author = {Huang, Mi and Li, Duanzhuo and Xia, Zhengzhen and Liao, Shengjie and Si, Wenxia and Yuan, Chao and Liao, Yanli and Wu, Weibin and Jiang, Minshu and Yu, Xin and Quan, Yi},
  title = {Silencing NRF2 enhances arsenic trioxide-induced ferroptosis in hepatocellular carcinoma cells},
  journal = {PLOS One},
  year = {2025},
  doi = {10.1371/journal.pone.0322746}
}
Kostenlos starten →